Diskusjon Triggere Porteføljer Aksjonærlister

Viking Therapeutics

Fortsatt ca 22,% short i denne.

https://fintel.io/ss/us/vktx

At de tør.

22% Placebo-Adjusted Weight Loss Reported at Week 33 Following Weekly Dosing of VK2735 at 17.5 mg; No Plateau Observed

Results Demonstrate Viability of Monthly and Every Other Week Dosing Regimens for Maintaining Weight Loss; Increasing Options for Adherence to Treatment

Up to 97% of Weight Loss Maintained Following Transition to Every Other Week Dosing for Three Months

Up to 90% of Weight Loss Maintained Following Transition to Monthly Dosing for Three Months

Excellent Tolerability Observed During Maintenance Dosing with GI Adverse Event Rates Similar to Placebo

Conference Call Scheduled for 8:00 a.m. ET Today

For noen resultater som kom i dag!

2 Likes

Begynte å lure på om du var ok, siden denne ikke kom i fedme-tråden, men glemte helt at @Investor lagde denne tråden i fjor høst

Pang-data

lav n

men pangdata likevel

1 Like